Patient Power®
Get Email Alerts!
Health Topics
View all Health Topics >
12/29/11

Breakthroughs in Chronic Lymphocytic Leukemia from ASH 2011

Dr. Steven Rosen, director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University in Chicago, shares his perspective about the latest chronic lymphocytic leukemia (CLL) news from the American Society of Hematology's 2011 annual meeting. Dr. Rosen explores CLL breakthroughs, including a new, non-chemotherapy treatment that may provide a better tolerated approach to treating the disease, especially for older patients and those with genetic variations that do not respond to the current standard of care.

Get Email Updates:

Get updated automatically when new content about Chronic Lymphocytic Leukemia has been posted.
Privacy Policy
Chronic Lymphocytic Leukemia

Experts & Guests

Steven T. Rosen,  M.D. Steven T. Rosen, M.D.
Director, Robert H. Lurie Comprehensive Cancer Center, Northwestern Memorial Hospital
Dr. Steven Rosen is the Genevieve Teuton Professor of Medicine and Director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. He received his medical degree from the Northwestern University Feinberg School of Medicine and completed his residency training at McGaw Medical Center of Northwestern University. Dr. Rosen is board certified in hematology, internal medicine and medical oncology.  more >

Related Videos

Dr. Susan O'Brien talks about the promise of therapy that may eventually replace chemotherapy treatment for some CLL patients

Watch Now

Dr. Michael Keating, President of the CLL Global Research Foundation, gives an overview of treatment and research from the past year and looks forward to 2012

Watch Now

Watch Now